2008
DOI: 10.1097/qai.0b013e3181743936
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial Vaginosis and Vaginal Yeast, But Not Vaginal Cleansing, Increase HIV-1 Acquisition in African Women

Abstract: BV and yeast may contribute more to the HIV epidemic than previously thought.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
99
2
3

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(111 citation statements)
references
References 25 publications
7
99
2
3
Order By: Relevance
“…The estrogen increases the glycogen content of vaginal epithelial cell activity; in turn inhibiting the in vitro growth of certain bacteria, which may result in low risk for bacterial vaginosis [19]. Our findings were supported with previous studies done in population of UK [27], Sweden [39], Netherlands [40], USA [20,41,42], turkey [43].…”
Section: Discussionsupporting
confidence: 82%
“…The estrogen increases the glycogen content of vaginal epithelial cell activity; in turn inhibiting the in vitro growth of certain bacteria, which may result in low risk for bacterial vaginosis [19]. Our findings were supported with previous studies done in population of UK [27], Sweden [39], Netherlands [40], USA [20,41,42], turkey [43].…”
Section: Discussionsupporting
confidence: 82%
“…Current epidemiological evidence using the above-mentioned diagnostic methods also suggests that any deviation from a lactobacilli-dominated cervicovaginal microbiome increases women's susceptibility to HIV and, in HIVpositive women, genital HIV shedding (Sha et al, 2005;van de Wijgert et al, 2008;Hayes et al, 2010). Furthermore, relationships between BV by Nugent scoring and herpes simplex virus type 2 (HSV-2; Cherpes et al, 2003), Neisseria gonorrhoeae, Chlamydia trachomatis (Wiesenfeld et al, 2003) and Trichomonas vaginalis (Rathod et al, 2011) have been described.…”
Section: Introductionmentioning
confidence: 99%
“…It could be argued that there is little value in characterizing the less dominant species; however, the etiology and ecology of BV are complex and poorly understood (27). We do not know what initiates the changes in microbial populations as they transition from healthy to abnormal compositions, what causes refractory or recurrent responses to treatment, whether there is a sexual transmission component, or whether specific compositions pose higher risks for the complications associated with BV in general (28)(29)(30)(31)(32)(33). It could also be argued that effective treatment of BV Escherichia coli ␄-P 36 Aggregatibacter ␄-P 37…”
Section: Figmentioning
confidence: 99%